Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Prestige And Intas Strike International Bevacizumab Deal

US And EU Filings Planned Next Year For HD204 Proposed Avastin Biosimilar

Jul 28 2022

• By Dave Wallace

Deal handshake global — Prestige and Intas have stuck a multi-territory deal for bevacizumab • Source: Shutterstock

Related Content

Accord Rolls Out Zercepac Trastuzumab Biosimilar In UK

Sep 25 2020

EMA Re-Examines Decisions On Prestige’s Trastuzumab And Synchron Studies

Jun 27 2022

Intas Picks Up Global Rights To Meiji And Dong-A’s Stelara Biosimilar

Jul 21 2021

Accord enters Europe as Coherus stays quiet

Oct 06 2018

Prestige And Pharmapark Add Bevacizumab To Russia Collaboration

Apr 16 2021

Accord’s Teriparatide And Fresenius Kabi’s Pegfilgrastim Satisfy CHMP

Jan 31 2022

Intas And Axantia Ink Middle East Ranibizumab Distribution Deal

Apr 06 2022

Related Companies

Prestige Biopharma Pte. Ltd.

Intas Pharmaceuticals Ltd.

Additional Topics

International Deals Biosimilars Strategy BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window